No attachments available.
Erlotinib Tablets
Contact and place of performance
Adam Hernandez
USA
No narrative description provided for this notice.
The National Institutes of Health, National Cancer Institute, issued an award notice for Erlotinib Tablets under solicitation number 75N91020Q00004. This procurement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. The award was processed as an SBA set-aside.
The place of performance for this contract is the United States, and the notice was published on January 27, 2020. Adam Hernandez is the designated point of contact for this requirement. There are zero attachments associated with this notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.